Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TCM kidney-tonifying phlegm-resolving blood-stasis-removing granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by Yueyang Hospital of Integrated Chinese and Western Medicine and the Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of polycystic ovary syndrome (PCOS), particularly in overweight or obese women. The formulation is designed to address the TCM pathological patterns of kidney deficiency, phlegm accumulation, and blood stasis, which are frequently associated with the metabolic and reproductive disturbances seen in PCOS. In clinical research, it is being evaluated as an adjunct to metformin to assess its impact on ovulation rates, hyperandrogenism, and metabolic parameters. As a complex herbal mixture, its mechanism involves multi-target regulation of the endocrine and metabolic systems, aiming to restore hormonal balance and improve insulin sensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TCM kidney-tonifying phlegm-resolving blood-stasis-removing granules.